A "two-hit" (chemo)therapy to improve checkpoint inhibition in cancer
Oncoscience
.
2021 May 7:8:55-57.
doi: 10.18632/oncoscience.533.
eCollection 2021.
Authors
Paolo Falvo
1
2
,
Stefania Orecchioni
1
2
,
Alessandro Raveane
1
2
,
Giulia Mitola
1
,
Francesco Bertolini
1
Affiliations
1
Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan 20141, Italy.
2
Contributed equally to this work.
PMID:
33997109
PMCID:
PMC8115984
DOI:
10.18632/oncoscience.533
No abstract available
Keywords:
T-cell therapy; anti-PD-1; breast cancer; chemotherapy; immunotherapy; lymphoma.